NCT05221255

Brief Summary

conservative management of functional constipation is a preferable method including biofeedback and spinal magnetic stimulation sessions

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

January 10, 2022

Completed
23 days until next milestone

First Posted

Study publicly available on registry

February 2, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
Last Updated

May 8, 2024

Status Verified

May 1, 2024

Enrollment Period

9 months

First QC Date

January 10, 2022

Last Update Submit

May 6, 2024

Conditions

Keywords

spinal magnetic stimulation, constipation

Outcome Measures

Primary Outcomes (5)

  • Number of weekly bowel movement

    Mean weekly complete spontaneous bowel movements.

    after 15 days

  • The Bristol Stool Scale (from 1 to 5)

    Stool consistency

    After 15 days

  • Numerical rating scale (from 0 to 10)

    pain assessment, zero indicates no pain, 10 indicates maximum pain degree

    After 15 days

  • Patient Assessment of Constipation Quality of Life questionnaire

    Assessment of quality of life (from 9 to 127) lower scores indicating fewer problems

    After 15 days

  • pressure manometry

    Assessment of pelvic floor power of contraction

    After 15 days

Secondary Outcomes (5)

  • Number of weekly bowel movement

    after one month

  • The Bristol Stool Scale (from 1 to 5)

    After one month

  • Numerical rating scale (from 0 to 10)

    After one month

  • Patient Assessment of Constipation Quality of Life questionnaire

    After one month

  • Pressure manometry

    After one month

Study Arms (2)

Sham Therapy

SHAM COMPARATOR

Patients will receive 12 sessions of biofeedback-assisted pelvic floor muscle relaxation plus non-real magnetic stimulation.

Other: spinal magnetic stimulation

Spinal magnetic stimulation

EXPERIMENTAL

Patients will receive 12 sessions of biofeedback-assisted pelvic floor muscle relaxation followed by real spinal magnetic stimulation.

Other: spinal magnetic stimulation

Interventions

* Biofeedback pelvic floor muscle training sessions will be performed for both groups for a total of 12 sessions. Menstruating women will be temporarily withdrawn from BF sessions till end of the menses. The session will last for 30 minutes of transrectal pressure biofeedback relaxation technique. Auditory and visual feedback will be provided in addition to positive verbal reinforcement. * Sham SMS will be used in the Sham group using the placebo program in the magnetic stimulation machine. * Spinal magnetic stimulation using the Neuro-MS/D machine. It will be used in spinal magnetic stimulation group, circular coil will be used to stimulate S2,3 and 4 sacral roots. Intensities will be adjusted to 50-70 % of maximal output (2.2 Tesla), stimulation frequency will be fixed at 20 Hz, burst length = 5 seconds, inter-burst interval = 25 seconds.

Sham TherapySpinal magnetic stimulation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adults patients diagnosed by Rome IV criteria as having functional constipation

You may not qualify if:

  • Patients younger than 18 years old.
  • Patients with irritable bowel syndrome.
  • Anal hemorrhoids or bleeding.
  • Any condition that may complicate bowel problems, such as Parkinson's disease, stroke, or traumatic brain injury.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nehad ElShatby

Alexandria, 25700, Egypt

Location

MeSH Terms

Conditions

Constipation

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Nehad ElShatby, MD,PhD

    Alexandria University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: interventional prospective trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physician

Study Record Dates

First Submitted

January 10, 2022

First Posted

February 2, 2022

Study Start

January 1, 2022

Primary Completion

October 1, 2022

Study Completion

October 1, 2022

Last Updated

May 8, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will share

All IPD will be available with the corresponding author for three years after publishing the study, and ready to be shared with other researchers

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
from date of publication and 3 years after
Access Criteria
Contact the corresponding author via dr.nehad@yahoo.com

Locations